Thursday , 26 December 2024
Home regulatory approval

regulatory approval

Alnylam Pharmaceuticals
Business

Alnylam Pharma’s Heart Drug Success Surges Stock

Alnylam Pharmaceuticals experienced a significant surge in its stock price, jumping by over 32%, following the successful outcomes of its drug vutrisiran in...